Filter
1560
Text search:
medicines
financing
Featured
Recommendations
132
New Publications
486
Language
Document type
No document type
855
Studies & Reports
320
Guidelines
140
Strategic & Response Plan
126
Manuals
69
Fact sheets
21
Situation Updates
12
Training Material
7
Resource Platforms
4
Infographics
4
Brochures
2
Countries / Regions
Global
105
Kenya
65
Uganda
46
Sierra Leone
43
Liberia
41
Ethiopia
37
Ghana
37
Africa
37
Western and Central Europe
36
India
35
Myanmar / Burma
34
Nigeria
33
Zambia
29
Ukraine
29
Bangladesh
26
Rwanda
25
South Africa
25
Malawi
25
Nepal
23
Tanzania
23
Namibia
20
Eastern Europe
20
Latin America and the Carribbean
19
Asia
15
Mozambique
13
Congo, Democratic Republic of
12
Philippines
12
East and Southern Africa
12
Cambodia
11
Zimbabwe
10
Indonesia
10
Lesotho
10
West and Central Africa
10
Middle East and North Africa
10
South–East Asia Region
10
Guinea
9
Botswana
9
Senegal
7
Cameroon
7
Haiti
7
Syria
7
Burkina Faso
6
Eastern Europe and Central Asia
6
Venezuela
6
Pakistan
5
Thailand
5
Eswatini/ Swaziland
5
Vietnam
5
Somalia
4
Sudan
4
Benin
4
Western Pacific Region
4
Tajikistan
4
Russia
4
North America
4
South Sudan
3
Jordan
3
Afghanistan
3
North Macedonia
3
Paraguay
3
Laos
3
Georgia
3
Gambia
2
China
2
Central African Republic
2
Ecuador
2
Bolivia
2
Libya
2
Yemen
2
Palestine
2
Albania
2
Southern Africa
2
Timor Leste/ East Timor
2
Qatar
2
Moldova
2
Kyrgyzstan
2
Jamaica
2
Mali
1
Saudi Arabia
1
Iraq
1
Germany
1
Lebanon
1
Egypt
1
Chad
1
Papua New Guinea
1
Peru
1
Brazil
1
Switzerland
1
Colombia
1
Sri Lanka
1
Chile
1
Other region
1
Djibouti
1
Armenia
1
Mongolia
1
Bulgaria
1
Iran
1
Uzbekistan
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
694
Public Health
113
Clinical Guidelines
80
Women & Child Health
60
Key Resources
48
Pharmacy & Technologies
10
Capacity Building
7
Toolboxes
HIV
144
TB
130
COVID-19
107
AMR
63
Health Financing Toolbox
60
Mental Health
53
Global Health Education
47
Pharmacy
46
Planetary Health
35
NCDs
31
Caregiver
29
Disability
28
Malaria
28
Conflict
25
NTDs
24
Ebola & Marburg
23
Rapid Response
18
Refugee
12
2.0 Rapid Response
11
Natural Hazards
10
Polio
6
Cholera
5
Zika
3
Specific Hazards
1
Social Ethics
1
The world has been turned on its head by the coronavirus disease 2019 (COVID-19) pandemic. This has provided a stark wakeup call on the severe under-financing of health systems around the world. It has laid bare the inequalities and limitations in t
...
This policy paper outlines key health financing policy actions for countries to ensure universal access to health services and financial protection for people fleeing conflict. It focuses on three policy areas – granting entitlement and ensure acc
...
The product of all this work is the Standard Treatment Guideline and Essential Medicines List of Common Medical Conditions in the Kingdom of Swaziland. These systematically developed statements are designed to assist practitioners in making decision
...
The GFF needs an additional US$2.5 billion from 2021 to 2025 to enable countries to protect health gains and accelerate progress toward the 2030 Goals. Of this amount, the GFF urgently needs to secure new pledges of US$1.2 billion by the end of 2021 to help its current 36 partner countries protect
...
During this work, a survey on essential medicines availability was conducted. This article was first written on this subject for sharing the poor financial availability of the essential medicines in
...
Annual and medium-term budget preparation processes are the platforms through which specific plans are transformed into actual resource allocation decisions. The aim of this Process Guide is to support key stakeholders involved in these processes (such as the Cabinet, Ministries of Finance and Healt
...
This paper was commissioned by N´weti and Wemos as part
of the project “Equitable health financing for a strong health
system in Mozambique”. Its purpose is to contribute to the
debate of the Mozambican Ministry of Health’s draft Health
S
...
Achieving financial risk protection for the whole population requires significant financing for health. Health systems in low- and middle-income countries (LMIC) are plagued with persistent underfunding, and recent reductions in official development
...
This comprehensive HPFM report thoroughly explores Kenya’s health financing landscape. It provides an in-depth analysis of the current state of affairs and sheds light on required strategic changes in health
...
The COVID-19 pandemic exposed critical gaps in the global response to health crises, particularly in the financing of pandemic prevention, preparedness, response, recovery, and reconstruction. This chapter presents a comprehensive framework for pand
...
Kenya Essential Medicines List 2019
recommended
The Kenya Essential Medicines List 2019 is an indispensable guide to the medicines recommended for the management of common conditions in Kenya. It is primarily directed at health care providers and
...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those
...
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t
...
Financing Global Health 2016: Development Assistance, Public and Private Health Spending for the Pursuit of Universal Health Coverage presents a complete analysis of the resources available for health in 184 countries, with a particular focus on dev
...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and
...
